TABLE 6.
Univariate Analysis of EFIC and Willingness Scores
| Variable | EFIC Score, Median (IQR) | p | Willingness Score, Median (IQR) | p |
|---|---|---|---|---|
| Group | 16 (14–18) | 82 (76–88.5) | ||
| Patient (n = 172) | 16 (14–16) | 0.50 | 81 (75–84) | 0.005 |
| Family (n = 73) | 16 (14–19) | 84 (76–92.5) | ||
| Community (n = 64) | 16 (13–18.75) | 83.5 (77–91) | ||
| Sex | ||||
| Male (n = 162) | 16 (14–17) | 0.58 | 81 (75–87) | 0.507 |
| Female (n = 147) | 16 (14–18) | 82 (76–90) | ||
| Age, y | ||||
| 18–24 (n = 64) | 16 (14–18) | 0.466 | 82 (76–86.75) | 0.205 |
| 25–34 (n = 57) | 16 (14–18) | 81 (73.5–86) | ||
| 35–49 (n = 83) | 16 (14–18) | 82 (76–91) | ||
| 50–64 (n = 76) | 16 (14–18) | 83.5 (76.25–91.75) | ||
| ≥65 (n = 29) | 16 (13.5–16) | 80 (75–84) | ||
| Race | ||||
| African American (189) | 16 (14–17.5) | 0.044 | 81 (75–86) | 0.118 |
| White (n = 102) | 16 (15–18) | 83 (76–92) | ||
| Other (n = 16) | 14 (13–16) | 84.5 (75.5–88.5) | ||
| Religion | ||||
| None (n = 55) | 16 (14–18) | 0.339 | 80 (74.5–88) | 0.413 |
| Judeo-Christian (n = 203) | 16 (14–18) | 82 (75.25–86.75) | ||
| Islam (n = 40) | 16 (14–17.75) | 81 (75.25–86.75) | ||
| Other (n = 11) | 16 (14.25–18) | 84.5 (76.75–89.25) | ||
| Education | ||||
| Some high school (n = 37) | 16 (14–18) | 0.50 | 80 (76–87) | 0.314 |
| High school graduate (n = 128) | 16 (14–17) | 82 (75–86) | ||
| Some college or technical school (n = 82) | 16 (14–18) | 84 (76–90) | ||
| College degree (n = 39) | 16 (13–19) | 82 (74–93) | ||
| Professional degree (n = 23) | 16 (15–20) | 84 (79–91) | ||
| Employment status | ||||
| Attending school (n = 18) | 16 (13–16.5) | 0.649 | 81 (74.5–89.25) | 0.683 |
| Part time (n = 41) | 16 (13–19) | 84 (76–91.5) | ||
| Full time (n = 111) | 16 (14–18) | 82 (75–91) | ||
| Unemployed/disabled (n = 137) | 16 (14–17) | 82 (76–85) | ||
| Previous participation in medical research | ||||
| Yes (n = 66) | 16 (14–17) | 0.367 | 84 (75–90.25) | 0.314 |
| No (n = 243) | 16 (14–17) | 82 (76–87) | ||
| Given permission for other to participate in medical research | ||||
| Yes (n = 17) | 16 (14–18) | 0.636 | 84 (70.5–90.5) | 0.843 |
| No (n = 292) | 16 (14–18) | 82 (76–88) | ||
| Experience with significant trauma requiring a transfusion | ||||
| Yes (n = 130) | 16 (14–18) | 0.339 | 82.5 (75.75–90) | 0.543 |
| No (n = 178) | 16 (14–18) | 82 (75.75–86) | ||
| Admitted following violent event | ||||
| Yes (n = 76) | 16 (13–16) | 0.035 | 81 (73–84) | 0.078 |
| No (n = 167) | 16 (14–18) | 82 (76–89) | ||
| The AVERT Shock Trial is an important study to perform | ||||
| Yes (n = 299) | 16 (14–18) | 0.007 | 82 (76–89) | 0.016 |
| No (n = 4) | 13.5 (9–16) | 82 (74.5–91) | ||
| Neutral (n = 6) | 12 (10–14) | 69 (60–77.25) | ||
Groups compared using the Kruskal-Wallis test. Significant differences underwent pairwise comparisons with adjusted significance of p < 0.05 reported.